UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033189
Receipt number R000037808
Scientific Title Comparison of magnifying endoscopy with narrow band imaging (ME-NBI) attached balloon versus colposcopy for diagnosing cervical cancer, including acceptability of the endoscope: An exploratory prospective study
Date of disclosure of the study information 2018/06/29
Last modified on 2020/11/18 16:59:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of magnifying endoscopy with narrow band imaging (ME-NBI) attached balloon versus colposcopy for diagnosing cervical cancer, including acceptability of the endoscope: An exploratory prospective study

Acronym

Comparison of magnifying endoscopy with narrow band imaging (ME-NBI) attached balloon versus colposcopy for diagnosing cervical cancer, including acceptability of the endoscope: An exploratory prospective study

Scientific Title

Comparison of magnifying endoscopy with narrow band imaging (ME-NBI) attached balloon versus colposcopy for diagnosing cervical cancer, including acceptability of the endoscope: An exploratory prospective study

Scientific Title:Acronym

Comparison of magnifying endoscopy with narrow band imaging (ME-NBI) attached balloon versus colposcopy for diagnosing cervical cancer, including acceptability of the endoscope: An exploratory prospective study

Region

Japan


Condition

Condition

Cervical intraepithelial neoplasma, uteri cervical cancer

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Comparability of diagnostic accuracy of ME-NBI versus colposcopy, and comparison of patient's tolerability on each examination

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitivity for detecting the highest lesion which is CIN2 or more

Key secondary outcomes

The visible rate of whole circumferential transition zone
The proportion of visible internal cervical canal
The complication rate
Comparison of patient's tolerability on each examination using questionnaire
The diagnostic accuracy of CIN at different stages (CIN1, CIN2, CIN3 or more)
Specificity, positive predictive value, and negative predictive value of CIN 2 or more detection


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Prior to colposcopy, endoscopic examination using ME-NBI and 3% acetic acid dispersion is attempted for approximately ten minutes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Female

Key inclusion criteria

Patients diagnosed as ASC-US, ASC-H, LSIL or HSIL by pap smear, or more than CIN3 by colposcopy are included.

Key exclusion criteria

Postoperative patients of cervical cancer, or patients with psychosis, or patients with pregnancy including suspicion are excluded.

Target sample size

95


Research contact person

Name of lead principal investigator

1st name Kunihisa
Middle name
Last name Uchita

Organization

Kochi Redcross Hospital

Division name

Gastroenterology

Zip code

780-8562

Address

Hadaminamimachi 1-4-63-11 Kochi city

TEL

088-822-1201

Email

ucchy31@yahoo.co.jp


Public contact

Name of contact person

1st name Kunihisa
Middle name
Last name Uchita

Organization

Kochi Redcross Hospital

Division name

Gastroenterology

Zip code

780-8562

Address

Hadaminamimachi 1-4-63-11 Kochi city

TEL

088-822-1201

Homepage URL


Email

ucchy31@yahoo.co.jp


Sponsor or person

Institute

Kochi Redcross Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Educaction, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kagawa University Hospital, Osaka International Cancer Institute

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kochi Redcross Hospital

Address

Hadaminamimachi 1-4-63-11 Kochi city

Tel

088-822-1201

Email

ucchy31@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

88

Results

The detection sensitivity for patients with CIN2+ was not statistically different between the two methods (both: 79%, 95% CI: 66%-88%). For diagnosing CIN2+, ME-NBI tended to show a higher sensitivity than colposcopy (69% vs 58%, respectively), while its specificity tended to be lower vs. colposcopy (55% vs 70%, respectively). Patients reported significantly less discomfort and embarrassment with ME-NBI vs colposcopy.

Results date posted

2020 Year 11 Month 18 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The 88 consecutive patients (median age: 40.5 years, range: 21-67 years) comprised 72 with positive PAP smear test results, 13 with follow-up HSIL, and 3 with definitive CIN3 confirmed by a referral hospital. HPV infection history was positive in 25 patients, negative in 5, and undetermined in 58. A history of HPV vaccination was present in 5 patients and absent in 83. The final diagnoses comprised non-cancerous lesions (8), CIN1 (32), CIN2 (13), CIN3 (34), and microinvasive carcinoma (1).

Participant flow

Eligible patients had positive PAP smear test results, suspicious high-grade CIN in previous colposcopy, or definitive CIN3 diagnosed previously. A gastrointestinal endoscopist examined the cervix using ME-NBI in an endoscopy room and, subsequently, a gynecologist blinded to the ME-NBI findings performed colposcopy in a different room. CIN2+ locations were documented in a scheme immediately after each examination. Punch biopsy samples were obtained from all areas diagnosed as CIN2+ with both methods and from one normal area.

Adverse events

none

Outcome measures

The primary outcome was the detection sensitivity of patients with CIN2+, comparing ME-NBI and colposcopy.
The secondary outcome measures were the rates of visible whole circumferential transition zones, visible cervical orifice, and complications. Patient acceptance of both methods was compared by a questionnaire survey evaluating patients discomfort and embarrassment. Increasing degrees of discomfort and embarrassment were scored from 1-5. Patients were also asked which examination they would choose in future.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 04 Month 26 Day

Date of IRB

2018 Year 04 Month 26 Day

Anticipated trial start date

2018 Year 04 Month 26 Day

Last follow-up date

2020 Year 07 Month 31 Day

Date of closure to data entry

2020 Year 07 Month 31 Day

Date trial data considered complete

2020 Year 08 Month 31 Day

Date analysis concluded

2020 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2018 Year 06 Month 28 Day

Last modified on

2020 Year 11 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037808


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name